Sandrine Aros-Calt

Sandrine Aros-Calt

Sandrine joined MedDay as a researcher in 2015 to develop qualitative and quantitative LC-MS and LC-MS/MS based metabolomic and lipidomic approaches applied to neurosciences. Sandrine completed a master degree in biotechnology for health from the University of Pharmacy (Angers). She has started her project manager career in 2008, serving as team manager successively for Bertin Pharma and Stallergenes companies. Until 2012, she was in charge of scientific projects in the field of molecular biology and immunology. In 2012, she began her PhD project and developed an original untargeted metabolomic method to study pathogenic bacteria in the Laboratory for Drug Metabolism Studies (CEA-LEMM, funded by bioMérieux). Sandrine obtained her PhD in Analytical Chemistry in 2015 (Univ. Paris-Saclay). In parallel, Sandrine is the chair of the French Metabolomics and Fluxomics Network – junior since 2016.

< Back

MedDay SA au capital de 116 660 €
Siège social : 96 Boulevard Haussmann 75008 Paris
RCS PARIS 534 957 865
Publication Director : Dr Frédéric Sedel